Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven Attia

Showing results (31-40 of 77) with videos related to

Pageof 8
Sort By:
Clinical Advances in Hematology & Oncology : H&O|March 7, 2008
Biologic study of the effects of octreotide-LAR on growth hormone in unresectable and metastatic hepatocellular carcinomaSteven Attia, Kyle D Holen, James P Thomas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 17, 2008
Randomized, double-blinded phase II evaluation of docetaxel with or without doxercalciferol in patients with metastatic, androgen-independent prostate cancerSteven Attia, Jens Eickhoff, George Wilding, et al.
Cancer Medicine|May 7, 2020
Clinical outcomes of patients with advanced synovial sarcoma or myxoid/round cell liposarcoma treated at major cancer centers in the United StatesSeth M Pollack, Neeta Somaiah, Dejka M Araujo, et al.
British Journal of Cancer|May 29, 2021
Phase II study of pazopanib with oral topotecan in patients with metastatic and non-resectable soft tissue and bone sarcomasBrian Schulte, Nisha Mohindra, Mohammed Milhem, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 29, 2024
Phase Ib Study of Unesbulin (PTC596) Plus Dacarbazine for the Treatment of Locally Recurrent, Unresectable or Metastatic, Relapsed or Refractory LeiomyosarcomaBrian A Van Tine, Matthew A Ingham, Steven Attia, et al.
Clinical and Translational Science|December 22, 2023
Pharmacokinetics of Dacarbazine and Unesbulin and CYP1A2-Mediated Drug Interactions in Patients With LeiomyosarcomaLan Gao, Diksha Kaushik, Brian A Van Tine, et al.
European Journal of Cancer (Oxford, England : 1990)|July 20, 2021
An open-label single-arm phase II study of regorafenib for the treatment of angiosarcomaMark Agulnik, Brian Schulte, Steven Robinson, et al.
Human Pathology|March 29, 2026
DICER1-Mutated Renal Neoplasia: A Series of 5 Cases Demonstrating the Spectrum of Cystic Nephroma, Wilms Tumor, and Anaplastic SarcomaDaniel Arizpe, Peter J Schoettler, Wendy A Allen-Rhoades, et al.
Hereditary Cancer in Clinical Practice|February 5, 2015
High-grade endometrial stromal sarcoma as the initial presentation of an adult patient with Peutz-Jeghers Syndrome: a case reportMaria Fernanda Noriega-Iriondo, Gerardo Colon-Otero, Benjamin R Kipp, et al.
Cancers|July 16, 2020
A Retrospective Analysis of the Efficacy of Immunotherapy in Metastatic Soft-Tissue SarcomasVarun Monga, Keith M Skubitz, Seth Maliske, et al.
Pageof 8

Showing results (31-40 of 77) with videos related to

Sort By:
Pageof 8
Clinical Advances in Hematology & Oncology : H&O|March 7, 2008
Biologic study of the effects of octreotide-LAR on growth hormone in unresectable and metastatic hepatocellular carcinomaSteven Attia, Kyle D Holen, James P Thomas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 17, 2008
Randomized, double-blinded phase II evaluation of docetaxel with or without doxercalciferol in patients with metastatic, androgen-independent prostate cancerSteven Attia, Jens Eickhoff, George Wilding, et al.
Cancer Medicine|May 7, 2020
Clinical outcomes of patients with advanced synovial sarcoma or myxoid/round cell liposarcoma treated at major cancer centers in the United StatesSeth M Pollack, Neeta Somaiah, Dejka M Araujo, et al.
British Journal of Cancer|May 29, 2021
Phase II study of pazopanib with oral topotecan in patients with metastatic and non-resectable soft tissue and bone sarcomasBrian Schulte, Nisha Mohindra, Mohammed Milhem, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 29, 2024
Phase Ib Study of Unesbulin (PTC596) Plus Dacarbazine for the Treatment of Locally Recurrent, Unresectable or Metastatic, Relapsed or Refractory LeiomyosarcomaBrian A Van Tine, Matthew A Ingham, Steven Attia, et al.
Clinical and Translational Science|December 22, 2023
Pharmacokinetics of Dacarbazine and Unesbulin and CYP1A2-Mediated Drug Interactions in Patients With LeiomyosarcomaLan Gao, Diksha Kaushik, Brian A Van Tine, et al.
European Journal of Cancer (Oxford, England : 1990)|July 20, 2021
An open-label single-arm phase II study of regorafenib for the treatment of angiosarcomaMark Agulnik, Brian Schulte, Steven Robinson, et al.
Human Pathology|March 29, 2026
DICER1-Mutated Renal Neoplasia: A Series of 5 Cases Demonstrating the Spectrum of Cystic Nephroma, Wilms Tumor, and Anaplastic SarcomaDaniel Arizpe, Peter J Schoettler, Wendy A Allen-Rhoades, et al.
Hereditary Cancer in Clinical Practice|February 5, 2015
High-grade endometrial stromal sarcoma as the initial presentation of an adult patient with Peutz-Jeghers Syndrome: a case reportMaria Fernanda Noriega-Iriondo, Gerardo Colon-Otero, Benjamin R Kipp, et al.
Cancers|July 16, 2020
A Retrospective Analysis of the Efficacy of Immunotherapy in Metastatic Soft-Tissue SarcomasVarun Monga, Keith M Skubitz, Seth Maliske, et al.
Pageof 8